AU752803B2 - Stress resistance gene - Google Patents
Stress resistance gene Download PDFInfo
- Publication number
- AU752803B2 AU752803B2 AU11675/99A AU1167599A AU752803B2 AU 752803 B2 AU752803 B2 AU 752803B2 AU 11675/99 A AU11675/99 A AU 11675/99A AU 1167599 A AU1167599 A AU 1167599A AU 752803 B2 AU752803 B2 AU 752803B2
- Authority
- AU
- Australia
- Prior art keywords
- plant
- aldose reductase
- cell
- protein
- homologous protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 128
- 241000196324 Embryophyta Species 0.000 claims description 146
- 102000004169 proteins and genes Human genes 0.000 claims description 96
- 150000001323 aldoses Chemical class 0.000 claims description 54
- 241000219823 Medicago Species 0.000 claims description 44
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 40
- 108010053754 Aldehyde reductase Proteins 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 33
- 230000035882 stress Effects 0.000 claims description 30
- 150000007523 nucleic acids Chemical class 0.000 claims description 26
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 24
- 108020004707 nucleic acids Proteins 0.000 claims description 24
- 102000039446 nucleic acids Human genes 0.000 claims description 24
- 238000011282 treatment Methods 0.000 claims description 23
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 claims description 21
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 16
- 102000016912 Aldehyde Reductase Human genes 0.000 claims description 15
- 150000003254 radicals Chemical class 0.000 claims description 15
- -1 sulphate ions Chemical class 0.000 claims description 11
- 150000001299 aldehydes Chemical class 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 230000001965 increasing effect Effects 0.000 claims description 8
- 231100000331 toxic Toxicity 0.000 claims description 8
- 230000002588 toxic effect Effects 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 7
- 229910001385 heavy metal Inorganic materials 0.000 claims description 7
- 230000001603 reducing effect Effects 0.000 claims description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 108091033319 polynucleotide Proteins 0.000 claims description 5
- 102000040430 polynucleotide Human genes 0.000 claims description 5
- 239000002157 polynucleotide Substances 0.000 claims description 5
- 108091034117 Oligonucleotide Proteins 0.000 claims description 4
- 230000036579 abiotic stress Effects 0.000 claims description 4
- 230000004790 biotic stress Effects 0.000 claims description 4
- 230000002939 deleterious effect Effects 0.000 claims description 4
- 239000004009 herbicide Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 230000002633 protecting effect Effects 0.000 claims description 2
- 230000002123 temporal effect Effects 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims 1
- 235000009685 Crataegus X maligna Nutrition 0.000 claims 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims 1
- 235000009486 Crataegus bullatus Nutrition 0.000 claims 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims 1
- 235000009682 Crataegus limnophila Nutrition 0.000 claims 1
- 235000004423 Crataegus monogyna Nutrition 0.000 claims 1
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- 235000002313 Crataegus paludosa Nutrition 0.000 claims 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims 1
- 108091006629 SLC13A2 Proteins 0.000 claims 1
- 238000003976 plant breeding Methods 0.000 claims 1
- 229910021653 sulphate ion Inorganic materials 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 description 45
- 108090000790 Enzymes Proteins 0.000 description 45
- 210000004027 cell Anatomy 0.000 description 45
- 229940088598 enzyme Drugs 0.000 description 45
- JVJFIQYAHPMBBX-UHFFFAOYSA-N 4-hydroxynonenal Chemical compound CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 description 44
- 230000009261 transgenic effect Effects 0.000 description 30
- 239000002299 complementary DNA Substances 0.000 description 29
- 230000014509 gene expression Effects 0.000 description 23
- 239000000758 substrate Substances 0.000 description 23
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 21
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- 238000009396 hybridization Methods 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 19
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 18
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 16
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 108020001507 fusion proteins Proteins 0.000 description 12
- 102000037865 fusion proteins Human genes 0.000 description 12
- 238000006467 substitution reaction Methods 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- 244000061176 Nicotiana tabacum Species 0.000 description 10
- 230000006378 damage Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 102000005602 Aldo-Keto Reductases Human genes 0.000 description 8
- 108010084469 Aldo-Keto Reductases Proteins 0.000 description 8
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 8
- 229930002875 chlorophyll Natural products 0.000 description 8
- 235000019804 chlorophyll Nutrition 0.000 description 8
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 8
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 229960002163 hydrogen peroxide Drugs 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 230000000243 photosynthetic effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 6
- 241000208125 Nicotiana Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- 125000003172 aldehyde group Chemical group 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 6
- 240000004658 Medicago sativa Species 0.000 description 5
- 235000010624 Medicago sativa Nutrition 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000009931 harmful effect Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000012261 overproduction Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 101000836540 Homo sapiens Aldo-keto reductase family 1 member B1 Proteins 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 229940044197 ammonium sulfate Drugs 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 229930192334 Auxin Natural products 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 101000836455 Rattus norvegicus Aldo-keto reductase family 1 member B1 Proteins 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002363 auxin Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000000254 damaging effect Effects 0.000 description 3
- 230000003412 degenerative effect Effects 0.000 description 3
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 3
- 230000005014 ectopic expression Effects 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- 108010050848 glycylleucine Proteins 0.000 description 3
- 108010085325 histidylproline Proteins 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 3
- 108010054155 lysyllysine Proteins 0.000 description 3
- 108010038320 lysylphenylalanine Proteins 0.000 description 3
- 230000000426 osmoregulatory effect Effects 0.000 description 3
- 230000008723 osmotic stress Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 108010061238 threonyl-glycine Proteins 0.000 description 3
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 2
- SITWEMZOJNKJCH-WDSKDSINSA-N Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SITWEMZOJNKJCH-WDSKDSINSA-N 0.000 description 2
- RZZMZYZXNJRPOJ-BJDJZHNGSA-N Ala-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C)N RZZMZYZXNJRPOJ-BJDJZHNGSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 2
- ABPRMMYHROQBLY-NKWVEPMBSA-N Gly-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)CN)C(=O)O ABPRMMYHROQBLY-NKWVEPMBSA-N 0.000 description 2
- LNCFUHAPNTYMJB-IUCAKERBSA-N His-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CN=CN1 LNCFUHAPNTYMJB-IUCAKERBSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 101000718007 Homo sapiens Aldo-keto reductase family 1 member A1 Proteins 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- FIJMQLGQLBLBOL-HJGDQZAQSA-N Leu-Asn-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FIJMQLGQLBLBOL-HJGDQZAQSA-N 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 2
- HUKLXYYPZWPXCC-KZVJFYERSA-N Met-Ala-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HUKLXYYPZWPXCC-KZVJFYERSA-N 0.000 description 2
- 101710197978 NADPH-dependent oxidoreductase Proteins 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- UXQFHEKRGHYJRA-STQMWFEESA-N Phe-Met-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O UXQFHEKRGHYJRA-STQMWFEESA-N 0.000 description 2
- ZVRJWDUPIDMHDN-ULQDDVLXSA-N Phe-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=CC=C1 ZVRJWDUPIDMHDN-ULQDDVLXSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 2
- 101000718035 Rattus norvegicus Aldo-keto reductase family 1 member A1 Proteins 0.000 description 2
- 101000717983 Rattus norvegicus Aldo-keto reductase family 1 member B7 Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- LHHDBONOFZDWMW-AAEUAGOBSA-N Trp-Asp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N LHHDBONOFZDWMW-AAEUAGOBSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- AUXMWYRZQPIXCC-KNIFDHDWSA-N (2s)-2-amino-4-methylpentanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O AUXMWYRZQPIXCC-KNIFDHDWSA-N 0.000 description 1
- RVLOMLVNNBWRSR-KNIFDHDWSA-N (2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O RVLOMLVNNBWRSR-KNIFDHDWSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- VBRDBGCROKWTPV-XHNCKOQMSA-N Ala-Glu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N VBRDBGCROKWTPV-XHNCKOQMSA-N 0.000 description 1
- BTBUEVAGZCKULD-XPUUQOCRSA-N Ala-Gly-His Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BTBUEVAGZCKULD-XPUUQOCRSA-N 0.000 description 1
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 1
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- RGQCNKIDEQJEBT-CQDKDKBSSA-N Ala-Leu-Tyr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 RGQCNKIDEQJEBT-CQDKDKBSSA-N 0.000 description 1
- XHNLCGXYBXNRIS-BJDJZHNGSA-N Ala-Lys-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XHNLCGXYBXNRIS-BJDJZHNGSA-N 0.000 description 1
- PEIBBAXIKUAYGN-UBHSHLNASA-N Ala-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 PEIBBAXIKUAYGN-UBHSHLNASA-N 0.000 description 1
- BDQNLQSWRAPHGU-DLOVCJGASA-N Ala-Phe-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N BDQNLQSWRAPHGU-DLOVCJGASA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- XAXMJQUMRJAFCH-CQDKDKBSSA-N Ala-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 XAXMJQUMRJAFCH-CQDKDKBSSA-N 0.000 description 1
- XSLGWYYNOSUMRM-ZKWXMUAHSA-N Ala-Val-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XSLGWYYNOSUMRM-ZKWXMUAHSA-N 0.000 description 1
- OMSKGWFGWCQFBD-KZVJFYERSA-N Ala-Val-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OMSKGWFGWCQFBD-KZVJFYERSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- ZJEDSBGPBXVBMP-PYJNHQTQSA-N Arg-His-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZJEDSBGPBXVBMP-PYJNHQTQSA-N 0.000 description 1
- LKDHUGLXOHYINY-XUXIUFHCSA-N Arg-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LKDHUGLXOHYINY-XUXIUFHCSA-N 0.000 description 1
- XNSKSTRGQIPTSE-ACZMJKKPSA-N Arg-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O XNSKSTRGQIPTSE-ACZMJKKPSA-N 0.000 description 1
- QADCERNTBWTXFV-JSGCOSHPSA-N Arg-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCNC(N)=N)N)C(O)=O)=CNC2=C1 QADCERNTBWTXFV-JSGCOSHPSA-N 0.000 description 1
- UGJLILSJKSBVIR-ZFWWWQNUSA-N Arg-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(O)=O)=CNC2=C1 UGJLILSJKSBVIR-ZFWWWQNUSA-N 0.000 description 1
- UGXVKHRDGLYFKR-CIUDSAMLSA-N Asn-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O UGXVKHRDGLYFKR-CIUDSAMLSA-N 0.000 description 1
- XQQVCUIBGYFKDC-OLHMAJIHSA-N Asn-Asp-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XQQVCUIBGYFKDC-OLHMAJIHSA-N 0.000 description 1
- ULRPXVNMIIYDDJ-ACZMJKKPSA-N Asn-Glu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N ULRPXVNMIIYDDJ-ACZMJKKPSA-N 0.000 description 1
- FMNBYVSGRCXWEK-FOHZUACHSA-N Asn-Thr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O FMNBYVSGRCXWEK-FOHZUACHSA-N 0.000 description 1
- LDGUZSIPGSPBJP-XVYDVKMFSA-N Asp-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)O)N LDGUZSIPGSPBJP-XVYDVKMFSA-N 0.000 description 1
- WYOSXGYAKZQPGF-SRVKXCTJSA-N Asp-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC(=O)O)N WYOSXGYAKZQPGF-SRVKXCTJSA-N 0.000 description 1
- SPKCGKRUYKMDHP-GUDRVLHUSA-N Asp-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N SPKCGKRUYKMDHP-GUDRVLHUSA-N 0.000 description 1
- CJUKAWUWBZCTDQ-SRVKXCTJSA-N Asp-Leu-Lys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O CJUKAWUWBZCTDQ-SRVKXCTJSA-N 0.000 description 1
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 1
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 1
- DONWIPDSZZJHHK-HJGDQZAQSA-N Asp-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N)O DONWIPDSZZJHHK-HJGDQZAQSA-N 0.000 description 1
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 1
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 1
- BOXNGMVEVOGXOJ-UBHSHLNASA-N Asp-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N BOXNGMVEVOGXOJ-UBHSHLNASA-N 0.000 description 1
- NWAHPBGBDIFUFD-KKUMJFAQSA-N Asp-Tyr-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O NWAHPBGBDIFUFD-KKUMJFAQSA-N 0.000 description 1
- QPDUWAUSSWGJSB-NGZCFLSTSA-N Asp-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N QPDUWAUSSWGJSB-NGZCFLSTSA-N 0.000 description 1
- JGLWFWXGOINXEA-YDHLFZDLSA-N Asp-Val-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 JGLWFWXGOINXEA-YDHLFZDLSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000209202 Bromus secalinus Species 0.000 description 1
- NIXHTNJAGGFBAW-CIUDSAMLSA-N Cys-Lys-Ser Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N NIXHTNJAGGFBAW-CIUDSAMLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- TUTIHHSZKFBMHM-WHFBIAKZSA-N Glu-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O TUTIHHSZKFBMHM-WHFBIAKZSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- JJSVALISDCNFCU-SZMVWBNQSA-N Glu-Leu-Trp Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O JJSVALISDCNFCU-SZMVWBNQSA-N 0.000 description 1
- CQAHWYDHKUWYIX-YUMQZZPRSA-N Glu-Pro-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O CQAHWYDHKUWYIX-YUMQZZPRSA-N 0.000 description 1
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 1
- JVACNFOPSUPDTK-QWRGUYRKSA-N Gly-Asn-Phe Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JVACNFOPSUPDTK-QWRGUYRKSA-N 0.000 description 1
- AYBKPDHHVADEDA-YUMQZZPRSA-N Gly-His-Asn Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O AYBKPDHHVADEDA-YUMQZZPRSA-N 0.000 description 1
- VAXIVIPMCTYSHI-YUMQZZPRSA-N Gly-His-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN VAXIVIPMCTYSHI-YUMQZZPRSA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- GWNIGUKSRJBIHX-STQMWFEESA-N Gly-Tyr-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)CN)O GWNIGUKSRJBIHX-STQMWFEESA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- FRJIAZKQGSCKPQ-FSPLSTOPSA-N His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CN=CN1 FRJIAZKQGSCKPQ-FSPLSTOPSA-N 0.000 description 1
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 1
- FLUVGKKRRMLNPU-CQDKDKBSSA-N His-Ala-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FLUVGKKRRMLNPU-CQDKDKBSSA-N 0.000 description 1
- TWROVBNEHJSXDG-IHRRRGAJSA-N His-Leu-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O TWROVBNEHJSXDG-IHRRRGAJSA-N 0.000 description 1
- PBJOQLUVSGXRSW-YTQUADARSA-N His-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CN=CN4)N)C(=O)O PBJOQLUVSGXRSW-YTQUADARSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- LBRCLQMZAHRTLV-ZKWXMUAHSA-N Ile-Gly-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LBRCLQMZAHRTLV-ZKWXMUAHSA-N 0.000 description 1
- QNBYCZTZNOVDMI-HGNGGELXSA-N Ile-His Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 QNBYCZTZNOVDMI-HGNGGELXSA-N 0.000 description 1
- FZWVCYCYWCLQDH-NHCYSSNCSA-N Ile-Leu-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N FZWVCYCYWCLQDH-NHCYSSNCSA-N 0.000 description 1
- UWBDLNOCIDGPQE-GUBZILKMSA-N Ile-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN UWBDLNOCIDGPQE-GUBZILKMSA-N 0.000 description 1
- PARSHQDZROHERM-NHCYSSNCSA-N Ile-Lys-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)N PARSHQDZROHERM-NHCYSSNCSA-N 0.000 description 1
- WMDZARSFSMZOQO-DRZSPHRISA-N Ile-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WMDZARSFSMZOQO-DRZSPHRISA-N 0.000 description 1
- BBIXOODYWPFNDT-CIUDSAMLSA-N Ile-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O BBIXOODYWPFNDT-CIUDSAMLSA-N 0.000 description 1
- CAHCWMVNBZJVAW-NAKRPEOUSA-N Ile-Pro-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)N CAHCWMVNBZJVAW-NAKRPEOUSA-N 0.000 description 1
- WKSHBPRUIRGWRZ-KCTSRDHCSA-N Ile-Trp-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)O)N WKSHBPRUIRGWRZ-KCTSRDHCSA-N 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 1
- RNKSNIBMTUYWSH-YFKPBYRVSA-N L-prolylglycine Chemical compound [O-]C(=O)CNC(=O)[C@@H]1CCC[NH2+]1 RNKSNIBMTUYWSH-YFKPBYRVSA-N 0.000 description 1
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 1
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 description 1
- LIINDKYIGYTDLG-PPCPHDFISA-N Leu-Ile-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LIINDKYIGYTDLG-PPCPHDFISA-N 0.000 description 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 1
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 1
- YRRCOJOXAJNSAX-IHRRRGAJSA-N Leu-Pro-Lys Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N YRRCOJOXAJNSAX-IHRRRGAJSA-N 0.000 description 1
- LSLUTXRANSUGFY-XIRDDKMYSA-N Leu-Trp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O LSLUTXRANSUGFY-XIRDDKMYSA-N 0.000 description 1
- YLMIDMSLKLRNHX-HSCHXYMDSA-N Leu-Trp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YLMIDMSLKLRNHX-HSCHXYMDSA-N 0.000 description 1
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 1
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 1
- GAOJCVKPIGHTGO-UWVGGRQHSA-N Lys-Arg-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O GAOJCVKPIGHTGO-UWVGGRQHSA-N 0.000 description 1
- HQVDJTYKCMIWJP-YUMQZZPRSA-N Lys-Asn-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HQVDJTYKCMIWJP-YUMQZZPRSA-N 0.000 description 1
- CANPXOLVTMKURR-WEDXCCLWSA-N Lys-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN CANPXOLVTMKURR-WEDXCCLWSA-N 0.000 description 1
- ATIPDCIQTUXABX-UWVGGRQHSA-N Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ATIPDCIQTUXABX-UWVGGRQHSA-N 0.000 description 1
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 1
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 1
- YSZNURNVYFUEHC-BQBZGAKWSA-N Lys-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YSZNURNVYFUEHC-BQBZGAKWSA-N 0.000 description 1
- RVKIPWVMZANZLI-ZFWWWQNUSA-N Lys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-ZFWWWQNUSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- 108010066427 N-valyltryptophan Proteins 0.000 description 1
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 1
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- ZWJKVFAYPLPCQB-UNQGMJICSA-N Phe-Arg-Thr Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O ZWJKVFAYPLPCQB-UNQGMJICSA-N 0.000 description 1
- HBGFEEQFVBWYJQ-KBPBESRZSA-N Phe-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HBGFEEQFVBWYJQ-KBPBESRZSA-N 0.000 description 1
- GRVMHFCZUIYNKQ-UFYCRDLUSA-N Phe-Phe-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O GRVMHFCZUIYNKQ-UFYCRDLUSA-N 0.000 description 1
- ROHDXJUFQVRDAV-UWVGGRQHSA-N Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ROHDXJUFQVRDAV-UWVGGRQHSA-N 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- FEPSEIDIPBMIOS-QXEWZRGKSA-N Pro-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 FEPSEIDIPBMIOS-QXEWZRGKSA-N 0.000 description 1
- VZKBJNBZMZHKRC-XUXIUFHCSA-N Pro-Ile-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O VZKBJNBZMZHKRC-XUXIUFHCSA-N 0.000 description 1
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 1
- SMFQZMGHCODUPQ-ULQDDVLXSA-N Pro-Lys-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SMFQZMGHCODUPQ-ULQDDVLXSA-N 0.000 description 1
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 description 1
- PCWLNNZTBJTZRN-AVGNSLFASA-N Pro-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 PCWLNNZTBJTZRN-AVGNSLFASA-N 0.000 description 1
- AFWBWPCXSWUCLB-WDSKDSINSA-N Pro-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 AFWBWPCXSWUCLB-WDSKDSINSA-N 0.000 description 1
- PGSWNLRYYONGPE-JYJNAYRXSA-N Pro-Val-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PGSWNLRYYONGPE-JYJNAYRXSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 1
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
- KAAPNMOKUUPKOE-SRVKXCTJSA-N Ser-Asn-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KAAPNMOKUUPKOE-SRVKXCTJSA-N 0.000 description 1
- JIPVNVNKXJLFJF-BJDJZHNGSA-N Ser-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N JIPVNVNKXJLFJF-BJDJZHNGSA-N 0.000 description 1
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- SBMNPABNWKXNBJ-BQBZGAKWSA-N Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO SBMNPABNWKXNBJ-BQBZGAKWSA-N 0.000 description 1
- OWCVUSJMEBGMOK-YUMQZZPRSA-N Ser-Lys-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O OWCVUSJMEBGMOK-YUMQZZPRSA-N 0.000 description 1
- IFLVBVIYADZIQO-DCAQKATOSA-N Ser-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N IFLVBVIYADZIQO-DCAQKATOSA-N 0.000 description 1
- WBAXJMCUFIXCNI-WDSKDSINSA-N Ser-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WBAXJMCUFIXCNI-WDSKDSINSA-N 0.000 description 1
- DINQYZRMXGWWTG-GUBZILKMSA-N Ser-Pro-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DINQYZRMXGWWTG-GUBZILKMSA-N 0.000 description 1
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 1
- OJFFAQFRCVPHNN-JYBASQMISA-N Ser-Thr-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O OJFFAQFRCVPHNN-JYBASQMISA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 101000836453 Sus scrofa Aldo-keto reductase family 1 member B1 Proteins 0.000 description 1
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 1
- XYFISNXATOERFZ-OSUNSFLBSA-N Thr-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XYFISNXATOERFZ-OSUNSFLBSA-N 0.000 description 1
- MGJLBZFUXUGMML-VOAKCMCISA-N Thr-Lys-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MGJLBZFUXUGMML-VOAKCMCISA-N 0.000 description 1
- VEIKMWOMUYMMMK-FCLVOEFKSA-N Thr-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VEIKMWOMUYMMMK-FCLVOEFKSA-N 0.000 description 1
- QOLYAJSZHIJCTO-VQVTYTSYSA-N Thr-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O QOLYAJSZHIJCTO-VQVTYTSYSA-N 0.000 description 1
- NQQMWWVVGIXUOX-SVSWQMSJSA-N Thr-Ser-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NQQMWWVVGIXUOX-SVSWQMSJSA-N 0.000 description 1
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 1
- KAFKKRJQHOECGW-JCOFBHIZSA-N Thr-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(O)=O)=CNC2=C1 KAFKKRJQHOECGW-JCOFBHIZSA-N 0.000 description 1
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- JZHJLBPBQKPTNX-UBHSHLNASA-N Trp-Cys-Ser Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 JZHJLBPBQKPTNX-UBHSHLNASA-N 0.000 description 1
- ONWMQORSVZYVNH-UWVGGRQHSA-N Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ONWMQORSVZYVNH-UWVGGRQHSA-N 0.000 description 1
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 1
- ZOBLBMGJKVJVEV-BZSNNMDCSA-N Tyr-Lys-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O ZOBLBMGJKVJVEV-BZSNNMDCSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 1
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 1
- AUMNPAUHKUNHHN-BYULHYEWSA-N Val-Asn-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N AUMNPAUHKUNHHN-BYULHYEWSA-N 0.000 description 1
- BVWPHWLFGRCECJ-JSGCOSHPSA-N Val-Gly-Tyr Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N BVWPHWLFGRCECJ-JSGCOSHPSA-N 0.000 description 1
- BNQVUHQWZGTIBX-IUCAKERBSA-N Val-His Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CN=CN1 BNQVUHQWZGTIBX-IUCAKERBSA-N 0.000 description 1
- IJGPOONOTBNTFS-GVXVVHGQSA-N Val-Lys-Glu Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O IJGPOONOTBNTFS-GVXVVHGQSA-N 0.000 description 1
- BGXVHVMJZCSOCA-AVGNSLFASA-N Val-Pro-Lys Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N BGXVHVMJZCSOCA-AVGNSLFASA-N 0.000 description 1
- LTTQCQRTSHJPPL-ZKWXMUAHSA-N Val-Ser-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N LTTQCQRTSHJPPL-ZKWXMUAHSA-N 0.000 description 1
- STTYIMSDIYISRG-UHFFFAOYSA-N Valyl-Serine Chemical compound CC(C)C(N)C(=O)NC(CO)C(O)=O STTYIMSDIYISRG-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000211 autoradiogram Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000004300 dark adaptation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000024346 drought recovery Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 230000019935 photoinhibition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 108010014563 tryptophyl-cysteinyl-serine Proteins 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000007279 water homeostasis Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Description
WO 99/25852 PCT/GB98/03464 STRESS RESISTANCE GENE The present invention relates to plant cells, breeding materials, plant parts and plants in which the expression level of the aldose reductase-homologous protein is increased and, therefore, which show higher resistance to stress conditions. Plant cells, breeding materials, plant parts and plants per se are provided and these are advantageously transgenic. The present invention further relates to nucleic acid eg.
DNA and RNA molecules and vectors suitable for providing expression of aldose reductase-homologous protein in cells and processes for the preparation of plant cells overproducing aldose reductase-homologous protein.
The invention has particular use in reducing damage in crops caused by harmful biotic and abiotic stress conditions and for improving harvest prospects thereby.
During their lifetime, plants are exposed to both abiotic (eg. photoinhibition by high light intensity, UV-B irradiation, ozone, heavy metals, high and low temperature, water deficiency, flooding and wounding) and biotic (eg. viral, bacterial and fungal infections, insect action) stress conditions. These stress conditions can cause serious decrease in plant productivity and economic damage; therefore, increasing plant stress tolerance and producing plants and breeding materials of higher stress resistance are among the major goals of plant breeders.
Aldose reductase (EC. 1.1.1.21) and aldehyde reductase (EC. enzymes belong to the aldo-keto reductase superfamily. These enzymes are monomeric NADPH-dependent oxidoreductases with broad substrate specificity, ranging from aldose sugars to aromatic aldehydes (Bohren K.M. et al. 1989. J. Biol. Chem. 264: 9547-9551). Until now plant aldose reductase enzymes were isolated only from monocots. The expression of the aldose reductase-homologous gene from b -ley is induced in the late period of embryo development (Bartels, D. et al. 1991. The EMBO J. 10: 1037-1043; Roncarati, R. 1995. The Plant Journal. 809-822). Experiments with bromegrass plants suggested a link between the expression of the aldose reductase-homologous gene and the low temperature tolerance of the cells (Lee, S.P.
1993. J. Plant Physiol. 142: 749-753). A series of studies point to an osmoregulatory function of aldose reductases in animal cells, because these enzymes can catalyse the WO 99/25852 PCT/GB98/03464 first step of the polyol reaction route: namely the reduction of D-glucose to sorbitol.
It is known that the modulation of the intracellular sorbitol level as well as other osmolytes serves to maintain the osmotic balance and the cellular volume (Moriyama, T. et al. 1989. J. Biol. Chem. 264: 16815-16821; Ferraris, J.D. 1996. J. Biol. Chem.
271: 18318-18321). However, there is still much uncertainty about the physiological function of these enzymes, because the high reactivity of aldose and aldehyde reductases with many aldehydes opens the possibility of a role for these enzymes as detoxificants in animal cells.
The potential mode of a detoxification role of these proteins can be summarised as follows: numerous pathological processes can generate harmful free radicals that can cause cell damage. Most of these free radicals have very short lifetime, their toxic effect being concentrated only to a small area around the site of their generation.
However, the reaction of these free radicals with membrane lipids leads to the formation of lipid peroxides and hydroperoxides that subsequently can undergo degradation which results in reactive aldehyde compounds. These aldehydes are much more stable than the free radicals, moreover, they can migrate away from the site of their formation, extending the toxic effect to the whole cell. One of the most frequently formed and most toxic lipid aldehydes is the 4-hydroxy-nonenal (HNE).
Because of its reactive a-P unsaturated double bond, HNE can spontaneously form Michael adducts with the -SH groups and lysine or histidine residues of cellular proteins. The aldehyde group of HNE can form Schiff bases with the a or E amino groups of proteins, thus via crosslinking it can alter their catalytic and structural properties. In nanomolar concentrations HNE can cause DNA damage while in higher, eg. micromolar, concentrations it has a cytotoxic effect.
Because HNE has an aldehyde group, a possible way of its detoxification is its reduction to alcohol, catalysed by the members of the aldo-keto reductase superfamily. Reviewing the literature, this detoxification role can be seen to be consistent with experimental results (Van der Jagt, D.L. et al. 1995 Biochim. Biophys.
Acta 1249: 117-126; Srivastava, S. et al. 1995. Biochem. Biophys. Res. Commun.
-2- WO 99/25852 PCT/GB98/03464 217: 741-746; Spycher S. et al. 1996. Biochem. Biophys. Res. Commun. 226: 512- 516; Spycher S. et al. 1997. FASEB J. 11: 181-187).
The object of the present invention is to produce novel, advantageously transgenic, plant types that, compared to the starting plants, ie. standard crop or ornamental lines, possess an enhanced resistance against both abiotic and biotic stress conditions and to provide a method for producing these.
The invention is based on the finding that, via overproduction of aldose reductase-homologous enzyme superfamily members having a general detoxificating and osmoregulatory effect, plant cells and plants regenerated from them can be made resistant to a greater extent against number of stress conditions of different origin at the same time. Particularly the effect of the enzyme is correlated to its ability to reduce aldehyde groups of various substrates, eg. 4-hydroxy-nonenal (HNE) and DLglyceraldehyde.
In reducing the invention to practice, cDNA coding for an alfalfa (Medicago sativa) aldose reductase-homologous enzyme (MsALRh) has been isolated by applying recombinant gene manipulation methods. By attaching this cDNA to a regulatory region, eg. a promoter, ensuring ectopic expression in plants, eg. by constitutive expression, in a functional relationship, eg.. in frame, overproduction of the aldose reductase-homologous enzyme has been carried out in cells of transgenic plants, thereby enabling the reduction of damage in said plants exposed to stress conditions of different origin via the detoxificating and/or osmoregulatory function of the aldose reductase-homologous protein.
Thus, in a first aspect the invention there are provided plants, plant cells, plant parts, breeding material and plant product, all of which are advantageously transgenic, which as a consequence of enhanced level of the aldose reductase-homologous enzyme present therein, show an enhanced resistance against the deleterious effects of a number of, and particularly against a wide variety of, stress conditions.
More specifically, the invention concerns plant cells that produce one or more aldose reductase-homologous superfamily enzymes capable of reducing aldehyde groups at an enhanced level and, therefore, which posses an enhanced resistance WO 99/25852 PCT/GB98/03464 against damaging effects of stress conditions involving the production of free radicals and/or against drought. Particularly provided is resistance against the damaging effects of free radical generation.
Plant cells, and thus plants, according to the invention advantageously overproduce an aldose reductase-homologous protein comprising the amino acid sequence presented in SEQ ID No 1, more preferably the alfalfa sequence in SEQ ID No 3 (MsALRh protein) or a functional variant or derivative thereof, said variant being advantageously at least 50% homologous, more advantageously at least homologous and even more advantageously at least 90% homologous to the aldose reductase-homologous protein sequence represented in SEQ ID No 1, and more preferably having such homology to the alfalfa protein of SEQ ID No 3. Still more preferably the cells and plants overproduce such enzymes comprising sequences having at least 50% identity, more preferably at least 70% identity and most preferably at least 90% identity with such sequences, most preferably with SEQ ID No 3.
Plant cells of the invention are advantageously transgenic and are transformed by incorporation therein of a nucleic acid molecule capable of expressing an aldose reductase-homologous protein. Plant cells, plant parts or plants according to the invention, however, can also be produced via traditional non-biological mutationselection methods wherein, for example, a chemical or UV-light is employed as the mutagenic agent and selection of plants for overproduction of aldose reductase superfamily enzyme of required activity is carried out using assays eg. as described below.The level of aldose reductase expression can be determined by hybridisation (using Northern or Western blot techniques, see Example 2) or via detection of the enzymatic activity, particularly that against HNE and/or DL-glyceraldehyde eg. as described below.
The invention further concerns plants and plant parts comprising plant cells according to the invention. Plants and plant parts according to the invention advantageously posses an enhanced level of resistance against stress conditions involving the production of free radicals, more specifically for example against WO 99/25852 PCT/GB98/03464 treatments with herbicides and/or heavy metals and/or producing hydrogen peroxide, and/or with NaCI; and/or infections caused by viruses and/or bacteria and/or fungi; and/or drought.
In a second aspect of the invention is provided nucleic acid sequences encoding an aldose reductase-homologous protein for use in the invention as well as recombinant nucleic acid molecules comprising such sequences. Particularly this nucleic acid is recombinant, isolated, enriched and/or cell free and encodes for the proteins described above having the aforesaid homology to SEQ ID No 1 or 3. This provides nucleic acid sequences coding for the aldose reductase-homologous protein, particularly for use in the invention and plant cells of the invention for use in producing plants and plant parts according to the invention.
By use of mutagenesis techniques, eg. such as SDM, the nucleic acids of the invention may be designed to encode the functional variants of the reductase proteins of the invention. Oligonucleotides and polynucleotides may also be used as probes and primers to identify further naturally occuring or synthetically produced reductase proteins using eg. southern or northern blotting Preferably the nucleic acid is DNA or RNA, particularly cDNA or cRNA and more preferably is characterised in that where it is a DNA it is a polynucleotide comprising nucleotide sequence having at least 80% identity with SEQ ID No 2 as listed in the sequence listing herein, or a sequence having degenerate substitution of codon nucleotides in that sequence, and where it is an RNA it has a complementary sequence wherein T is replaced by U. Preferably the identity is 90% or more, more preferably 95% or more and most preferably 100%. Preferably non-identical parts of the sequences comprise degenerate substitutions.
Most preferred DNA or RNA is that which is capable of hybridizing with one or both strands of the nucleic acid of SEQ ID No 2, and polynucleotide and oligonucleotide fragments thereof of 15 or more contiguous bases, preferably 30 or more and more preferably 100 or more, selected from a characteristic region of the sequence with respect to nucleic acid encoding for other superfamily enzymes, under WO 99/25852 PCT/GB98/03464 high stringency conditions, more preferably being capable of such hybridization with two or more of these polynucleotides or oligonucleotides. Most suitable selections of sequences for performing these hybridizations will be selected from coding regions of SEQ ID No 2 coding for parts that are unconserved with respect to the other members of the superfamily.
Thus with reference to Figure 1 below it will be seen that amino acids 41 to 49 and 250 to 256 tend to be conserved within the superfamily and thus these sequences as such are unsuitable for use in selecting hybridizing sequences for selecting the preferred homologs of alfalfa type other than in a screen for superfamily members in general.
In a third aspect of the invention is provided nucleic acid encoding for an aldose reductase homologous protein superfamily member, in the form of a vector or contruct, combined in frame with a promoter, activating or otherwise regulating sequence capable of promoting its expression ectopically in plants, either constituitively or locally, eg. in vegetative or root tissues. Conveniently this expression is non-temporal, ie.unlike the Rocarati et al promoter, such that the plant tissue is protected from the damaging effects of free-radicals, eg. generation of HNE, at all times.
It will be realised by those skilled in the art that tissue specific regulatory regions, such as tissue specific promoters, may be used where a specific tissue requires protection from stress related toxins and/or osmoregulation. Examples of tissue specific promoters will be known to those skilled in the art, but may be exemplified by those of WO 97/20057 (incorporated herein by reference) teaching root specific promoters and those of Rocarti et al, being embryo and seed specific. For protection of vegetative tissues, tissue specific promoters may be used but constuitive promoters such as CaMv35S and alfalfa (MsH3gl) (see WO 97/20058 incorporated herein by reference) will have useful application.
In a fourth aspect of the invention there is provided a process for producing plant cells overproducing an aldose reductase-homologous protein, which comprises WO 99/25852 PCT/GB98/03464 the transformation of a plant cell with a nucleic acid molecule according to the invention.
In a fifth aspect of the present invention there is provided a transgenic plant or part thereof comprising recombinant nucleic acid, a vector or construct as described above.Preferred plants of the fifth aspect may comprise the nucleic acid of the invention in a construct in functional association with promoter, activating or otherwise regulating sequences. Preferred promoters may be tissue specific such that the resultant expression of protein, and thus its effects, are localised to a desired tisssue. Promoters with a degree of tissue specificity will be known to those skilled in the art of plant molecular biology.
Methods of producing vectors and constructs capable of being used in the present invention will occur to those skilled in the art in the light of conventional molecular biology techniques. DNA, RNA and vectors containing or encoding for these may be introduced into target cells in known fashion in the field of plant cell transformation. Particularly preferred is the method of introducing the DNA or RNA into cells, more particularly pollen cells, using techniques such as electroporation or gene gun technology.
It may be preferred to express the DNA or RNA of the invention throughout the plant, but in the event that tissue specific effect is to be exploited then it will be understood by those skilled in the art that tissue specific promoters, enhancers or other activators should be incorporated into the transgenic cells employed in operative relation with the DNA.
Numerous specific examples of methods used to produce transgenic plants and plant cells by the insertion of cDNA in conjunction with suitable regulatory sequences will be known to those skilled in the art. Plant transformation vectors have been described by Denecke et al (1992) EMBO J. 11, 2345-2355 and their further use to produce transgenic plants producing trehalose described in US Patent Application Serial No. 08/290,301. EP 0339009 B1 and US 5250515 describe strategies for inserting heterologous genes into plants (see columns 8 to 26 of US 5250515).
Electroporation of pollen to produce both transgenic monocotyledonous and -7- WO 99/25852 PCT/GB98/03464 dicotyledonous plants is described in US 5629183, US 7530485 and US 7350356.
Further details may be found in reference works such as Recombinant Gene Expression Protocols. (1997) Edit Rocky S. Tuan. Humana Press. ISBN 0-89603-333- 3; 0-89603-480-1 (all these references being incorporated herein by reference). It will be realised that no particular limitation on the type of transgenic plant cell or plant to be provided is envisaged; all classes of plant, monocot or dicot, may be produced in transgenic form incorporating the nucleic acid of the invention such that aldehyde, particularly HNE, reducing activity in the plant is altered, constituitively or ectopically.
Further aspects of the invention provide alfalfa homologous protein and antibodies raised thereto.
The below-defined terms will be used with the given meaning throughout the whole specification and in the claims even if said given meaning would anyway differ from the meaning of the said term as generally used in the art.
An "aldose reductase-homologous protein" is defined in this description as an enzyme being a member of the aldo-keto reductase superfamily and similarly to other members of this family can reduce the aldehyde group of a wide variety of substrates in the presence of NADPH cofactor. The term "aldose reductase-homologous protein" as used herein also includes functional variants and derivatives of the said protein.
A "functional variant" or a "functional derivative" of a protein is a protein the amino acid sequence of which can be derived from the amino acid sequence of the original protein by the substitution, deletion and/or addition of one or more amino acid residues in a way that, in spite of the change in the amino acid sequence, the functional variant retains at least a part of at least one of the biological activities of the original protein that is detectable for a person skilled in the art. A functional variant is generally at least 50% homologous (preferably the amino acid sequence is at least identical), advantageously at least 70% homologous and even more advantageously at least 90% homologous to the protein from which it can be derived.
A functional variant may also be any functional part of a protein; the function in the present case being particularly but not exclusively aldehyde reduction.
-8- WO 99/25852 PCT/GB98/03464 Preferably the amino acid sequence differs from SEQ ID No 1 or SEQ ID No 3 mainly or only by conservative substitutions. More preferably the protein comprises an amino acid sequence having 90% or more, still more preferably 95%, sequence identity with SEQ ID No 1 or SEQ ID No 3 and optimally 100% identity with those sequences.
Algorithms and software suitable for use in aligning sequences for comparison and calculation of sequence homology or identity will be known to those skilled in the art. Significant examples of such tools are the Pearson and Lipman search based FAST and BLAST programs. Details of these may be found in Altschul et al (1990), J. Mol. Biol. 215: 403-10; Lipman D J and Pearson W R (1985) Science 227, p1435- 41. Publically available details of BLAST may be found on the internet at 'http://www.ncbi. nlm.nih.gov/BLAST/blast-help.html'. Thus such homology and identity percentages can be ascertained using commercially or publically available software packages incorporating, for example, FASTA and BLASTn software or by computer servers on the internet. An example of the former is the GCG Wisconsin Software package while both Genbank (see http://www.ncbi.nlm.nih.gov/BLAST) and EMBL: (see http://www.embl-heidelberg.de/Blast2) offer internet services.
By the term identity is meant that the stated percentage of the claimed amino acid sequence or base sequence is to be found in the reference sequence in the same relative positions when the sequences are optimally aligned, notwithstanding the fact that the sequences may have deletions or additions in certain positions requiring introduction of gaps to allow alignment of the highest percentage of amino acids or bases. Preferably the sequence are aligned by using 10 or less gaps, ie. the total number of gaps introduced into the two sequences when added together is 10 or less.
The length of such gaps is not of particular importance as long as the aldehyde reducing activity is retained but generally will be no more than 10, and preferably no more than 5 amino acids, or 30 and preferably no more than 15 bases.
Preferred parameters for BLAST searches are the default values, ie. for EMBL Advanced Blast2: Blastp Matrix BLOSUMS, Filter default, Echofilter X, Expect WO 99/25852 PCT/GB98/03464 Cutoff default, Strand both, Descriptions 50, Alignments 50. For BLASTn defaults are again preferably used. GCG Wisconsin Package defaults are Gap Weight 12, Length weight 4. FASTDB parameters used for a further preferred method of homology calaculation are mismatch penalty 1.00, gap penalty =1.00, gap size penalty 0.33 and joining penalty =30.0.
The expression 'high stringency conditions' will be understood by those skilled in the art, but are conveniently exemplified as set out in US 5202257, Col 9- Col 10, which is incorporated herein by reference.
The expression 'degenerative substitution' refers to substitutions of nucleotides by those which result in codons encoding for the same amino acid; such degenerative substitutions being advantageous where the cell or vector expressing the protein is of such different type to the DNA source organism cell that it has different codon preferences for transcription/translation to that of the cDNA source cell. Such degenerative substitutions will thus be host specific.
The expression 'conservative substitutions' as used with respect to amino acids relates to the substitution of a given amino acid by an amino acid having physicochemical characteristics in the same class. Thus Where an amino acid in the SEQ ID No 1 or SEQ ID No 3 has a hydrophobic characterising group, a conservative substitution replaces it by another amino acid also having a hydrophobic characterising group; other such classes are those where the characterising group is hydrophilic, cationic, anionic or contains a thiol or thioether. Such substitutions are well known to those of ordinary skill in the art, i.e. see US 5380712 which is incorporated herein by reference, and are only contemplated where the resultant protein has activity as an aldehyde reducing enzyme, particularly acting upon HNE, eg. in the presence of NADPH.
A protein or RNA is said to be "produced at enhanced level" or "overproduced" if the concentration of the said protein in the cell where it is produced is at least higher than that in the original cell, ie. a cell of the original plant line which has now been transformed. Similarly, a plant, a plant tissue or a plant cell is defined as having WO 99/25852 PCT/GB98/03464 an "enhanced level of resistance" to a harmful condition if it can withstand a enhanced effect of the same harmful condition, without detectable damage, than the original plant, plant tissue or plant cell. Overproduction of a molecule in a cell can be achieved via both traditional mutation and selection techniques and genetic manipulation methods.
The term "ectopic expression" is used herein to designate a special realisation of overproduction in the sense that, for example, an ectopically expressed protein is produced at a spatial point of a plant where it is naturally not at all (or not detectably) expressed, that is, said protein is overproduced at said point. Particular types of ectopic expression will comprise eg. expression of the aldo-keto reductase protein in vegetative tissues or roots of a plant, whereas normally it may be found only temporally expressed through transcripts in embryo and/or pollen (see Roncarati et al).
The present invention will now be further described by way of illustration only by reference to the following non-limiting Examples, Figures and Sequence listing.
Further Examples falling within the scope of the invention will occur to those skilled in the art in the light of these.
SEQUENCE LISTING: The sequences of the sequence listing attached hereto are those as follows: SEQ ID No 1: Amino acid sequence shared by preferred aldose reductasehomologous enzymes to which homology of the enzymes for use in the present invention is related.
SEQ ID No 2: DNA including cDNA encoding for an alfalfa (Medicago satvia) aldose reductase-homologous enzyme for use in the present invention.
SEQ ID No 3: Amino acid sequence of an alfalfa (Medicago satvia) aldose reductase homologous enzyme for use in the present invention.
SEQ ID No 4 and 5 are those of primers referred to in Example 3.
FIGURES
-11- WO 99/25852 PCT/GB98/03464 Figure 1: is a comparison of the amino acid sequence of the alfalfa MsALRh protein to human, animal and plant aldose and aldehyde reductase proteins.
Figure 2 shows the results of Southern hybridisation of genomic DNA isolated from alfalfa. 20utg of genomic DNA was digested with restriction enzymes indicated in the figure below each lane. The restriction fragments were separated on 1% agarose gel and blotted onto Hybond-N membrane. P-32 labelled coding region fragment of the MsALRh CDNA was used as hybridization probe.
Figure 3 shows the results of Northern hybridisation experiments with the MsALRh cDNA. Total RNA was isolated from alfalfa A2 cell suspension treated with 150pM ABA (abscisic acid) hormone 10% polyethylene glycol (PEG 4000, 3b) and cadmium chloride 20p.g total RNA was electrophoresed on a 1% formaldehyde-agarose gel and transferred onto Hybond-N membrane, and subsequently probed with P-32 labelled coding region of the MsALRh cDNA fragment. C in each case is untreated control.
Figure 4 depicts a Western hybridisation analysis of the MsALRh gene expression. 4a shows the level of protein in different alfalfa tissues with longer (upper) and shorter expression time. 4b shows the change of protein level during PEG, 250pM cadmium chloride and 1mM hydrogen peroxide treatments.
Figure 5 is a map of a vector of pGEX origin (pGEX-5X-3) suitable for the expression of the cDNA encoding the enzyme. The vector expresses the enzyme as a glutathion-S-transferase fusion protein in E. coli cells.
Figure 6 shows purification of MsALRh-GST fusion protein on glutathione- Sepharose.
Figure 7 shows the effect of ammonium sulphate treatment on the activity of the MsALRh-GST recombinant fusion protein. Enzymatic activity on 10mM DLglyceraldehyde substrate was measured spectrophotometrically by determining the measure of NADPH oxidation at 340 nm. The standard reaction mixture comprised pg enzyme and 0.15 mM NADPH. Before starting the activity measurement, the enzyme was preincubated with ammonium-sulfate for 3 minutes.
-12- WO 99/25852 PCT/GB98/03464 Figure 8 shows the Western hybridisation detection of the aldose reductasehomologous protein in cell extracts isolated from the leaves of transgenic tobacco plants.
Figure 9a and 9b show the results of light induced fluorescence measurements of control and transgenic plant leaf discs during 20pM paraquat (9a) and 250pM cadmium chloride (9b) treatments.
Figures 10a, 10b, 10c and 10d demonstrate the results of germination tests of control (SRI) and transgenic 1/5, 1/9) plants in control 0 conditions (10a), in the presence of 15mM hydrogen peroxide (10b), 150aM cadmium chloride (10c) and 250mM sodium chloride Figure 11 shows results of light induced fluorescence measurements during water deficient growth of control (SRI) and transgenic (TR1/4, 1/7, 1/1, 1/5 and 1/9) plants.
Figure 12a shows a photograph of control and transgenic plants after 10 days of rehydration after a 35 day severe drought treatment. 12b shows detection of the aldose reductase-homologous protein in cell extracts made from leaves of control and transgenic plants shown in 12a after the aforesaid drought tolerance experiment.
Figure 13 illustrates the photsynthetic efficiency measured as Gentry-parameter of chlorophyll fluorescence in tobacco leaves before (day during (days 2-4) and after (day 8 and day 15) UV-B irradiation. Full circles represent average data for plants 1/1, 1/5, 1/8, 1/9 and 1/10. Empty circles represent data from plants 1/4 1/7 and control SRI.
Experiments In the experimental examples below the inventors demonstrate the isolation of a gene encoding an alfalfa (Medicago sativa) aldose reductase-homologous protein, in cDNA form. Its nucleotide sequence and the deduced amino acid sequence verified that the isolated cDNA codes for a novel plant aldose reductase-homologous protein that has not been identified so far. The isolated aldose reductase cDNA was cloned into a plant expression vector and by the means of a generally used gene introduction -13- WO 99/25852 PCT/GB98/03464 method transformed tobacco plants were produced. Beyond the molecular biological characterization of the transgenic tobacco plants their increased tolerance to different stress conditions has also been shown.
Example 1.
Isolation of the alfalfa aldose reductase-homologous cDNA (MsALRh) from a gene bank and prediction of the encoded amino acid sequence For the preparation of the alfalfa cDNA library and the identification of the aldose reductase-homologous cDNA widely used molecular biology methods were applied according to the protocols of Sambrook, J. et al. (Sambrook, J. et al.: Molecular cloning, A Laboratory Manual, 2nd edition, Cold Spring Harbour N.Y., 1989, incorporated herein by reference). The details of the procedure can be summarised as the following: The alfalfa cDNA library was produced as follows.
Total cellular RNA was isolated from in vitro cultivated auxin shock activated alfalfa tissues, which contained dedifferentiated callus tissues and high number of somatic embryos. Stress activation (auxin shock) was performed by using 2,4dichloro-phenoxyacetic acid (an auxin analog) applying a method known per se so as to enhance the concentration of stress induced mRNAs. The mRNA isolation method applied is detailed in Cathala et al. (1983 DNA 2: 329-335) incorporated herein by reference.
The mRNA molecules were then separated from the total RNA by the means of oligo-dT cellulose chromathography according to the method of Aviv, H. and Leder, P. (1972 Proc Natl. Acad. Sci. USA 69: 1408-1412) incorporated herein by reference.
The first cDNA strand was then synthesised on the isolated poly-A+ (mRNA) fraction with an oligo-dT primer using AMV reverse transcriptase enzyme. Synthesis of the second DNA strand was done using DNA polymerase I enzyme, removal of the excess of template mRNA was performed via RNase H treatment. Synthesis of polydC tails to the end of the synthesised cDNA and poly-dG tails to PstI digested pGEM2 vector (Promega) end was done using terminal transferase enzyme. After -14- WO 99/25852 PCT/GB98/03464 annealing and ligation using T4 DNA ligase the constructs were transformed into MC1061 E. coli strain and the transformation mixture was plated out onto 100 mg/l ampicillin containing selective LB-plates. Using 25 p.g DNA, 2.5X105 primary transformant colonies were obtained. It was shown that approx. 96% of the clones contained inserts of detectable sizes. The preparation procedure of the cDNA library followed widely used protocols of the art and was especially based on that of De Loose et al. (1988 Gene 70: 13-23) incorporated herein by reference.
The nucleotide sequence of about a hundred individual clones of this cDNA library cDNA clones prepared from a stress induced mRNA isolate) was determined. Before sequencing, the inserts were subcloned into plasmid pUC 19 and the sequencing reaction was carried out on double stranded DNA using the dideoxy chain termination method with ct-35-S-dATP labelling. For the sequencing reactions the T7 Sequencing Kit (Pharmacia) and Sequenase 2.0 Kit (US Biochem) were used, according to the manufacturers' protocols.
Using the determined cDNA sequence, Genebank and EMBL nucleotide sequence databases were homology searched. The result showed that the amino acid sequence derived from the clone later designated MsALRh has homology to both human, rat and plant aldo-keto reductase proteins. The length of the MsALRh cDNA is 1231 base pairs and the coding region can be located between 34 and 975 nucleotides (SEQ ID no This region codes for a 313 amino acid protein. The amino acid sequence of the alfalfa aldose reductase-homologous protein showed 44.3% identity with the known and best characterised monocot barley aldose reductase-homologous protein and it has 46.2% and 46.1% identity with human aldehyde reductase and pig aldose reductase enzymes, respectively (Fig. It further showed a 42% amino acid identity to the dicotyledonous soybean NADPH-dependent oxidoreductase enzyme. The observed level of amino acid homology led us to conclude that the cloned alfalfa cDNA codes for a novel enzyme of the aldo-keto reductase superfamily.
WO 99/25852 PCT/GB98/03464 Example 2.
Molecular biological characterisation of the alfalfa aldose reductase-homologous gene The thorough molecular biological characterisation of the alfalfa aldose reductase-homologous gene according to the invention showed that its behaviour differed from the known plant aldose reductase-homologues. The copy number of the gene in the alfalfa genome was analysed with Southern hybridisation; the expression of the gene was analysed by Northern hybridisation on the mRNA level and by Western hybridisation on the protein level.
Genomic DNA was isolated from alfalfa cells and the purified DNA was digested with restriction endonucleases. The MsALRh cDNA fragment carrying full length coding sequence was used as probe for the Southern hybridisation experiments after radioactive isotope labelling using the "random priming" method (Freinberg, A.P. and Vogelstein, B. 1983. Anal. Biochem. 137: 266-267). The hybridisation was carried out in Rapid-hyb buffer (Amersham) at 65 0 C. The result of the hybridisation (Fig. 2) showed that the aldose reductase-homologous gene has a low copy number but faint additional bands on the autoradiogram present at al restriction digestion might indicate the presence of other gene homologues in the alfalfa genome.
The expression of the gene was analyzed by Northern hybridisation using generally known methods [Sambrook, J. et al.: "Molecular cloning, A Laboratory Manual" (2 nd edition, Cold Spring Harbour 1989.) incorporated herein by reference]. The analysis can be detailed as follows: Total RNA was purified from alfalfa A2 cell suspension according to the method of Maes (1992. Nucl. Acids Res. 20: 4374) incorporated herein by reference.
After separation on formaldehyde-agarose gel the RNA was transferred onto Hybond- N membrane (Amersham). Full length coding region of the MsALRh gene was radioactively labeled using the "random priming" method (Freinberg, A.P. and Vogelstein, B. 1983. Anal. Biochem. 137: 266-267, incorporated herein by reference) and hybridizations were carried out at 65 0 C in Rapid-hyb hybridisation buffer (Amersham). The tissue specificity experiments revealed that the alfalfa aldose reductase-homologous gene is expressed in each tissue in contrary to the barley aldose -16- WO 99/25852 PCT/GB98/03464 reductase-homologue, which was expressed only temporally and only in embryos.
The alfalfa cell suspension was exposed to different hormone and stress treatments.
The results indicated that the studied gene is homoinduced. Treatment with the plant stress hormone abscisic acid (ABA) significantly enhanced the RNA level 4 hours after its initiation (Fig. The importance of this finding lies in the fact that hormone ABA is a key compound in the regulation of several genes that play important role in the adaptation to environmental stresses such as drought and low temperature.
Treatment with polyethylene-glycol results in an osmotic stress in plant cells.
Expression of the MsALRh gene could be induced by such an osmotic stress as well as by cadmium-chloride treatment (heavy metal stress; Fig. Cadmium ion is known to induce oxidative stress beside its photosynthetic inhibitory property and in these cases the level of lipid peroxides increases in the plant cells. As it was also disclosed in the introduction, the decomposition products of the lipid peroxides are those lipid aldehydes that can serve as substrates of the aldo-keto reductases in the detoxification reactions.
Example 3.
Biochemical characteristics of the alfalfa aldose reductase-homologous protein In order to characterise the substrate specificity of the enzyme, a recombinant protein was produced and purified in a prokaryotic protein expression system.
The cDNA of the MsALRh gene was cloned into pGEX 4T-1 prokaryotic expression vector (Pharmacia) and the GST (gluthathion-S-transfarase) containing fusion protein was produced in and purified from E. coli. Using the purified fusion protein as antigen, rabbit polyclonal antibody was raised by conventional techniques.
This antibody was used to analyse, by Western hybridization, the effects of different stress treatments on the production of the MsALRh protein and to detect the protein in different tissues of the alfalfa plant (Fig. 4).
The coding region (975 bp) of the MsALRh cDNA was PCR amplified, using "primer (5'-cgaactcgagatggccacagcaatcaagttt-3') as upper and "primer2" ccgagctctacttcaccatcccagag-3') as lower primer (XhoI restriction sites in the primers -17- WO 99/25852 PCT/GB98/03464 are underlined) according the method of Mullis and Faloona (1987 Meth. Enzymol.
155: 335) incorporated herein by reference. The PCR product was digested with Xhol restriction endonuclease and the digested fragment was cloned into the XhoI site of the pGEX 4T-1 vector (Pharmacia). The nucleotide sequence of the cloned product was verified in order to avoid PCR generated errors.
In order to induce the production of the N-terminal GST containing fusion protein (MsALRh-GST protein, later on) the transformant E. coli cells were treated with 0.5 mM isopropyl-p-D-galactopyranoside (IPTG) at 25 0 C for 3 hours.
Transformants expressing the fusion protein were identified according to the method of Smith and Johnson (1988 Gene 67: 31-40) incorporated herein by reference. The MsALRh-GST fusion protein was purified on glutathione-Sepharose 4B columns following the instructions of the manufacturer's protocol (Pharmacia).
The produced and purified MsALRh-GST fusion protein (100-150 4tg in 0.5 ml) was thoroughly mixed with the same volume of complete Freund's adjuvant (Sigma) and rabbit was immunised with this emulsion. Two subsequent immunisations were made with the emulsion of the antigen and incomplete Freund's adjuvant after 3 and 6 weeks, respectively. The blood serum was checked in Western analysis. The specificity of the serum for the MsALRh protein was tested in a competition experiment.
For the Western blot analysis, proteins of the alfalfa cell suspension extracts were separated on a 12% SDS-polyacrylamide gel. After separation, the proteins were transferred onto nitrocellulose membrane. The blood serum raised against the fusion protein was used as first antibody (in 1:2000 dilution); anti-rabbit-IgG antibody conjugated with peroxidase was used as second antibody in these experiments. The antigen-antibody complex was detected using Super SignalRTM CL-HRP Substrate System (Pierce), a high sensitivity chemiluminescent detection method.
The presence of the MsALRh protein in different tissue types of the alfalfa plant was examined. The result clearly indicated (Fig. 4a) that the protein can be found in each tested plant organ. This result is absolutely in contrast with those published by Bartels, D. et al. (1991. The EMBO J. 10: 1037-1043) because the barley aldose -18- WO 99/25852 PCT/GB98/03464 reductase-homologous protein was not present in detectable amounts in vegetative tissues. Our result showed the difference of the alfalfa aldose reductase-homologous protein from the previously isolated plant aldose reductases and may indicate it's different physiological role, as well.
The increase in the amount of the MsALRh protein during osmotic stress induced by PEG treatment or during heavy metal stress induced by cadmium-chloride treatment as well as due to toxic free radical production by hydrogen peroxide treatment was also detected by the Western hybridisation technique (Fig. 4b). These results showed that the increase of the MsALRh protein level during osmotic and heavy metal stress correlated with the observed increase of the mRNA level of the gene and showed that the oxidative stress-inducing hydrogen-peroxide treatment also increased the MsALRh protein level in alfalfa cells. These results strongly support a role for the MsALRh protein in plant defence reactions against the toxic effect of reactive free radicals.
The substrate specificity tests of the MsALRh enzyme besides the amino acid homology proved that the MsALRh gene codes for an enzyme belonging to the aldoketo reductase superfamily and, at the same time, it also has numerous different characteristics as compared to the so far characterised plant aldose reductasehomologues. Enzymatic activity of the MsALRh-GST fusion protein on different substrates was measured photometrically: measuring the decrease of the concentration of the NADPH cofactor at 340 nm wavelength at 25 0 C during a 5 minutes reaction time. One ml of the reaction mixture contained 50 mM sodium-phosphate buffer 0.1 mM NADPH as cofactor and different concentrations of the substrates.
One enzyme activity unit is expressed as the enzyme amount (in mg) which is necessary for the oxidation of 1 p.mol NADPH in one minute in the presence of the substrate. Aldose sugars, DL-glyceraldehyde and 4-hydroxy-nonenal (ICN Biochemicals) were used as substrates in these specificity measurements, and the results (as Km kinetic constants) are shown in Tables 1-3 below. According to our results the purified enzyme is able to reduce aldehyde substrates in the presence of NADPH cofactor. High enzymatic activities could only be measured on DL- -19- WO 99/25852 PCT/GB98/03464 glyceraldehyde (known as the best substrate for plant aldose reductase-homologues) and on 4-hydroxy-nonenal. The MsALRh enzyme could reduce D-xylose with much less activity and showed no activity on other aldose substrates (such as D-glucose, Dgalactose, D-mannose or D-ribose) even at very high (400 mM) substrate concentrations. According to the results (Table 1 below) the alfalfa enzyme showed very similar activity on glyceraldehyde substrate as compared to the animal aldehyde reductases. At the same time, it works less effectively in the presence of 4-hydroxynonenal (Table 2).
Table 1 0 Comparison of Km kinetic parameters on DL-glyceraldehyde substrate of plant aldose reductase-homologues and mammalian aldehyde reductases ENZYME Km/mM 1. MsALR 3,18 2. Barley ALR 56,0 3. Human aldehyde reductase 1,6 4. Rat aldehyde reductase 8,35 Table 2 Km kinetic parameters of aldose reductase enzymes on 4-hydroxy-nonenal substrate ENZYME Km/tM 1. MsALR 700 2. Human aldose reductase 22 3. Calf aldose reductase 8,8 WO 99/25852 PCT/GB98/03464 Table 3 Alteration of the activity of aldose and aldehyde reductases as a consequence of a treatment with 0.3 M (NH 4 2 S0 4 ENZYME RELATIVE ACTIVITY 1. MsALR 192,8 2. Human aldose reductase 277,0 3. Rat aldehyde reductase 97,0 We have examined whether the MsALRh enzyme could reduce the aldehyde group of 4-hydroxy-nonenal (HNE), which was mentioned earlier as one of the degradation products of the lipid peroxides, thus eliminating its previously disclosed toxic effect. Our results showed that the HNE is better substrate for the MsALRh than the DL-glyceraldehyde, formerly known to be the best substrate for plant aldose reductases. The Km kinetic constant value for HNE is approx. 700 jtM that is about 1/3 of the value having been measured on glyceraldehyde. These measurements were first carried out using the ALRh-GST fusion protein but in the subsequent experiments measurements were repeated with protein from which the GST-tag was removed via a cleavage by thrombin at the thrombin recognition site present between the MsALRh and the GST moieties. The Km values for both DL-glyceraldehyde and 4-hydroxy-nonenal were the same in both cases thus we could conclude that the GST fusion partner did not alter the substrate specificity of the MsALRh enzyme.
The S0 4 2 ions are known to alter the enzymatic activity of rat aldose and aldehyde reductases in a different manner. In our case the resulted twofold increase in the enzymatic activity in the presence of 0.3 M ammonium-sulfate is a characteristic of the aldose reductases (Fig. An important property of the MsALRh enzyme is that it's activity increases by 100% even in the presence of low concentration (45 mM) of ammonium-sulfate. This result may indicate that the advantageous effect of the enzyme can be increased in the transgenic plants by ammonium-sulfate treatment. Based on these results we can conclude that the MsALRh enzyme, as well, as the barley aldose reductase-homologous enzyme, has -21 WO 99/25852 PCT/GB98/03464 also similar characteristics to both the animal aldose and aldehyde reductases but it possesses specific different characteristics, too.
Example 4.
Insertion of the alfalfa aldose reductase-homologous (MsALRh) cDNA into tobacco plants to produce the aldose reductase protein in the vegetative organs of transgenic plants Foreign genes can be introduced into plant genomes by the Agrobacteriumbased transformation system (for details see: Hiche, E. et al. "Plant Cell and Tissue Culture" 1994. pp. 231-270, ed. Vasil, I.K. and Thorpe, Kluwer Academic Publisher) incorporated herein by reference. The cDNA studied was fused to the viral promoter disclosed in Benfey et al. 1989. EMBO J. 8: 2195-2202 incorporated herein by reference.
The produced binary vector construct was mobilized into an Agrobacterium strain, tobacco leaves were infected by scratching, co-cultivation was performed and kanamycin resistant plants were regenerated according to Claes et al. (1991. The Plant J. 1: 15-26) incorporated herein by reference. Transformant plants and seeds obtained by self-pollinating were used in the germination experiments.
The functioning of the alfalfa aldose reductase gene in transgenic tobacco plants was proved by immunological methods.
Expression of the aldose reductase gene in the transgenic tobacco plants was verified by Western blot analysis using the polyclonal antibody raised against the MsALR-GST fusion protein. Ten tobacco lines were analysed (Fig. Protein extracts obtained from the leaves of these lines were tested according to the western hybridisation protocol detailed previously except that the protein samples were separated on 10% SDS-polyacrylamide denaturing gel and alkaline phosphatase conjugated anti-IgG antibody was used as second antibody. The antibody-protein complex was detected by BCIP (5-bromo-4-chloro-3-indolyl-phosphate) and NBT (2,2'-di-p-nitrophenyl-3,3'-[3,3'-dimethoxi-4,4'-diphenylene]-ditetrazolium-chloride) substrates. Synthesis of considerable amount of the MsALRh protein could be -22- WO 99/25852 PCT/GB98/03464 detected in five of the ten examined transgenic lines, the other transgenic lines showed no expression of the MsALRh gene and no signal could be detected in the control wild type (SRI) plant, either.
Example Transformant tobacco plants expressing alfalfa aldose reductase-homologous protein show elevated level of tolerance against different stress treatments, such as herbicide, heavy metal, hydrogen peroxide and sodium chloride In order to verify the concept of the invention, the behaviour of the transformants were tested in the presence of paraquat (PQ) herbicide and cadmium Leaf discs were cut from the leaves of control SRI and transformants and treated with paraquat (20 RM) and cadmium chloride (250 piM) solutions in Petridishes. The functional damage of the photosynthetic apparatus was monitored by light induced fluorescence measurements using PAM fluorimeter according to Vass.
I. et al. (Biochem. 1996. 35: 8964-8973). The decrease of the fluorescence intensity in the case of the control SRI plant showed considerable damage after a 24 hour treatment and this effect was more pronounced after 48 hours. In contrast, the intensity decreased much less in the case of the transgenic lines and thus showed a significantly reduced loss of photosynthetic functions (Fig. 9).
Germination tests were also used to check the stress resistance of the transformants. After self-pollination, seeds from the transformants were grown on culture media containing 15 mM hydrogen peroxide, 150 pM cadmium chloride and 250 mM sodium chloride, respectively. The seeds were germinated under controlled conditions in the light. As Fig. 10 shows every transformant line is more resistant to the applied stress treatments than the control SRI tobacco plants. The protective effect of the expressed MsALRh protein clearly appears to be concentration dependent as transgenic line 1/5 was found to be the most tolerant against these treatments and this line expressed the transgene at the highest level.
-23- WO 99/25852 PCT/GB98/03464 Example 6.
Transgenic tobacco lines producing the alfalfa aldose reductase-homologous protein show resistance against water deficiency Transformant tobacco plants were grown in soil under controlled greenhouse conditions for 5 weeks and the water content of the soil was measured at the beginning of the experiment. The damage of the photosynthetic system was monitored during the experiment by light induced fluorescence measurements as detailed in the above experiments. Prior to the beginning of the experiment we have selected plants with similar developmental stage from the transgenic tobacco lines and the SRI control plants and leaves with the same age were chosen on each plant for the fluorescence measurements to be made at given time points during the experiment.
At the beginning of the experiment we stopped the watering of the tested plants.
Between days 32 and 35 of the water deficient growth the Fv/Fm fluorescence values showing viability of the plants dropped intensively in the case of the SRI plant and lines 1/4 and 1/7 (Fig. 11), while did not decrease significantly in the case of the lines 1/1, 1/5 and 1/9. The tested plants on day 45 of the experiment are shown on Fig. 12.
After the desiccation period the humidity of the soil was determined. At this point the plants were rehydrated for 10 days and the light induced fluorescence values of the pre-selected leaves were measured again. In the case of lines 1/1, 1/5 and 1/9 these values were about the same as the day 45 values or slightly better, however, in the case of the SRI control and the non-expressing 1/4 and 1/7 lines the Fv/Fm value continued to decrease. After rehydration, protein extracts were isolated from the leaves and the MsALRh protein level was determined (Fig. 13). The result shows that in SR1, 1/4 and 1/7 plants the protein was not detectable, whereas in 1/1, 1/5 and 1/9 lines the MsALRh protein was present. Thus we could conclude that only those plants could tolerate desiccation that expressed the MsALRh protein.
In order to prove that this increased drought resistance was not due to the different water storage capability of the leaves, the dehydration experiment was repeated on single leaves. The results showed, that the speed of water loss was approximately the same in both MsA1Rh protein producing and control plants.
-24- WO 99/25852 PCT/GB98/03464 Example 7.
UV-B irradiation protection.
Tobacco plants were kept in a ventilated growth chamber for five test days at 26 0
C.
Photosynthetically active radiation was provided from fluorescent tubes (Tungsten at 60-80p.mol m 2
S-
2 intensity from above and from the side between 8am and 6pm daily. UV-B (280-320nm) irradiation was provided from UV-B 313 tubes (Qpanel, USA) at 7.5ltmol m- 2 s 2 total UV-B intensity from above between 9am and 3pm daily, for 4 days starting from the second day of the test. To exclude the effect of possible UV-C (X 280nm) irradiation, one layer of cellulose acetate filter (Courtaulds Chemicals UK) was placed between the plants and the UV-B source.
During the recovery period plants were kept in the green house under normal growth conditions.
For chlorophyll fluorescence measurement plants were transferred to the laboratory. Measurement was performed in the dark and was completed in ca. minutes including the initial 15 minutes dark adaptation. After this plants were transferred back to the growth chamber or (during the recovery period) to the green house. All chlorophyll fluorescence measurements were performed in the afternoon between ca 3 and Untreated plants were measured in the afternoon of the first test day, before starting UV-B irradiation at the second test day. UV-B irradiated plants were measured on the 2 "d- 5 th test days, 30 minutes after cessation of irradiation.
Chlorophyll fluorescence was measured with a PAM Chlorophyll Fluorometer (WALZ Company, Germany) using weak umol m- 2 s-2) modulated red light Steady state (Fs) and maximal fluorescence yields were measured before and upon a 0.5s saturating white light pulse (2500 p.mol m' 2 respectively, in 11.5p~mol m-2 s- 2 actinic red light. Efficiency of the photosynthetic electron transport was characterised with the Gentry-parameter, calculated as Two leaves were tested on each plant and two chlorophyll fluorescence measurements were performed on each leaf, on the adaxial side, symmetrically on both sides of the midrib.
WO 99/25852 PCT/GB98/03464 Results: Plant leaves showed visible symptoms of UV-B damage, ie. spots with damage pigmentation, from the third day of the test, after two days of UV-B irradiation. These became more intense during further irradiation and remained on the leaves even during the recovery period. Chlorophyll fluorescence indicated decline of photosynthetic efficiency (Gentry parameter) from the firstUV-B irradiation day. In the case of plants 1/1, 1/5, 1/8, 1/9 and 1/10 this recovered to ca. 90% of original after one week recovery in the greenhouse. In the control SR1, 1/4 and 1/7 plants there was no marked recovery.
Photosynthetic efficiency was measured as the Gentry-parameter of chlorophyll fluorescence in tobacco leaves before (day during (days 2-4) and after (days 8 and UV-B irradiation. In Figure 13 full circles represent average data obtained using plants 1/1, 1/5, 1/8, 1/9 and 1/10. Empty circles represent average data measured in plants 1/4, 1/7 and SRI.
Summarising the results of the above-detailed experiments and considering the biochemical characteristics of the enzyme we can conclude that: The isolated alfalfa aldose reductase-homologous gene codes for an enzyme of novel characteristics, which can react with the toxic lipid aldehyde 4hydroxy-nonenal.
Transgenic plants expressing the alfalfa aldose reductase-homologous gene were produced to make use of these and other characteristics of the enzyme and the produced plants were proven to be resistant against a wide range of harmful stress treatments.
The described examples clearly prove the usefulness of the concept of the invention, which was also supported by theoretical considerations, namely, plants overproducing the alfalfa aldose reductase-homologous enzyme have an increased resistance against numerous stress conditions of diverse origin.
As the fundamentally novel approach of the invention does not comprise any species specific essential feature, the skilled person can reasonably conclude that plant cells of any species overproducing aldose reductase-homologous protein of any origin -26- 27 will have an enhanced resistance against numerous different stress conditions.
Based on the above demonstrated results, considering that the general protecting effect of the aldose reductase-homologous protein is most probably based on the disclosed basic cell biological processes, one can also reasonably conclude that the approach of the invention is also useful for developing resistance against further stress conditions, for example against high or low temperature, UV-B irradiation, and plant pathogen action.
"Comprises/comprising" when used in this specification is taken to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof.
oe *o o *oe• o*oee *oee EDITORIAL NOTE FOR 11675/99 THE FOLLOWING SEQUENCE LISTING IS PART OF THE DESCRIPTION THE CLAIMS FOLLOW ON PAGE 28 WO 99/25852 WO 9925852PCT/GB98/03464 SEQUENCE LISTING <110> Oberschaj., Attila Horvath Dr, Gabor Deak Dr, Maria Torok, Karolyne Dudits Dr, Denes Feher Dr, Attila Sass, Laszlo Hideq Dr, Eva Vass Dr, Imre BTG International Ltd <120> Stress resistance gene <130> 137980/PCT <140> <141> <150> HU P9702118 <151> 1997-11-18 <150> HU P9702118 <151> 1998-03-09 <150> HU P9702118 <151> 1998-04-21 <160> <170> Patentln Ver. <210> 1 <211> 306 <212> PRT <213> Medicago sativa <400> 1 Phe Gin Leu Asn Thr Gly Ala I 1 5 Trp Gin Ala Glu Pro Gly Xaa Y Xaa Xaa Gly Tyr Arg His Ile A Ser Giu Ile Gly Ser Ala Leu 1 Lys Arg Giu Glu Leu Trp Ile T 70 His Pro Giu Asp Val Pro Lys A Xaa Xaa Xaa Xaa Xaa Xaa Xaa X 100 Ile Xaa 25 Cys Lys Ser Leu Xaa 105 Pro 10 Xaa Ala Leu Lys Asp 90 Ile Leu Gly Xaa Xaa Lys Asn Gly Val Ser Asp Xaa Xaa Val Ser 110 Thr Xaa Gin Val His Xaa met WO 99/25852 Lys Arg Gly 115 PCT/GB98/03464 His Ala Asp Thr Gly Giu Phe Met Gly Clu Asn 120 Leu Asp 125 Ile Pro 130 Ala Lys 145 Leu Leu His Pro Gly Ile Lys Ser 210 Leu Giy 225 Gly His Asn Leu Phe Ser Ser Ala Asp Giy His 195 Asp Lys Ser Asp Giu 275 Thr Ile Val Trp 180 Leu Ile Thr Val Val 260 Ile Trp Gly Ala 165 Gin Ser Leu Pro Leu 245 Tyr Lys Lys Ala 135 Vai Ser 150 Arg Val Gin Ala Gly Tyr Lys Asn 215 Giy Gin 230 Pro Lys Asp Trp Gin Asp Lou Gly Asn Phe Pro Pro Lys Lou 185 Ser Pro 200 Pro Vai Val Ala Ser Thr Ser Ile 265 Lys Leu 280 Ala Ser Ala 170 His Leu Val Leu Asn 250 Pro Ile Leu Tyr Asp 140 Thr Lys Lys 155 Vai Asn Gin Ala Phe Cys Gly Ser Pro 205 Lys Giu Ile 220 Arg Trp Giy 235 Giu Ala Arg Giu Asp Leu Lys Gly Thr 285 Ser Leu Vai Giu 190 Giy Ala Lou Ile Phe 270 Phe Gly Lys Gin Asp 160 Giu Lou 175 Ser Lys Vai Lou Giu Lys Gin Ala 240 Lys Lys 255 Pro Lys Phe Val Asri Asp Thr Tyr Giy Ala Phe Arg Thr Ile Giu Giu Leu Trp Asp Giy 290 295 300 Giu Val 305 <210> 2 <211> 1231 <212> DNA <213> Medicago sativa <220> <221> CDS <222> (34)..(972) <400> 2 attcaataaa aaccacatat tcatggctcc aaa atg gcc aca gca atc aag ttt Met Ala Thr Ala Ile Lys Phe 1 ttt cag ttg aac act ggt gct aaa atc cct tca gtt ggt tta ggt act Phe Gin Leu Asn Thr Gly Ala Lys Ile Pro Ser Vai Gly Leu Giy Thr 15 WO 99/25852 tgg caa get Trp Gin Ala PCT/GB98/03464 gaa oct ggt gtt gtt goc aaa got gtc aco act got gtt 150 Glu Pro Gly Val Val Ala Lys Ala Val Thr Thr Ala Val 30 cag Gin tea Ser aag Lys cat His oag Gin aaa Lys 120 ata Ile get Ala cta Leu oac His gga Gly 200 aaa Lys ott Leu gtt Vai gag Glu cgo Arg cca Pro ctt Leu 105 agg Arg cca Pro aaa Lys ttg Leu cct Pro 185 att Ile agt Ser 9gg Gly gga Gly att Ile gag Glu gaa Glu gat Asp gga Gly agc Ser get Ala gao Asp 170 gga Gly oat His gao Asp aag Lys tao Tyr ggt Gly gag Glu gat Asp tao Tyr aca Thr aca Thr att Ile 155 gta Val tgg Trp cta Leu att Ile aca Thr 235 aga Arg tea Ser tta Leu gtt Val ott Leu ggt Gly tgg Trp 140 gga Gly gca Ala cag Gin tot Ser ott Leu 220 oca Pro cat His 45 get Ala tgg Trp oca Pro gao Asp gaa Glu 125 aaa Lys gto Val aga Arg cag Gin gga Gly 205 aag Lys gga Gly att Ile ctc Leu ate Ile aaa Lys otc Lau 110 ttt Phe gca Ala ago Ser gtg Val gca Ala 190 tat Tyr aat Asn oaa Gin gat Asp aaa Lys aco Thr gca Ala 95 tat Tyr atg Met ttg Leu aat Asn cct Pro 175 aag Ly.
tct Ser cca Pro' gtt Vai tgt Cys aag Lys tea Ser 80 ttg Leu ctg Leu ggt Gly gga Gly tto Phe 160 cca Pro ttg Leu cot Pro gtt Val gco Ala 240 get gaa Ala Glu 50 ott ttt Leu Phe 65 aaa ota Lye Leu gat aaa Asp Lye ate cac Ile His gaa aat Glu Asn 130 gca ota Ala Leu 145 tct aca Ser Thr get gtt Ala Val oat gca His Ala ota ggo Leu Gly 210 gto aaa Val Lye 225 ott oga Leu Arg get Ala gag Glu tgg Trp act Thr tgg Trp 115 ott Leu tat Tyr aag Lye aat Asn ttt Phe 195 tea Ser gag Glu tgg Trp tat Tyr gat Asp tgt Cys tta Leu 100 cca Pro gat Asp gao Asp aaa Lys cag Gin 180 tgt Cys cca Pro att Ile ggt Gly aag Lye ggt Gly tea Ser aat Asn gtg Vai oat His tct Ser ott Leu 165 gtg Val gaa Glu gga Gly gca Ala cta Leu 245 aat Asn gtg Val gat Asp gat Asp ago Ser gee Ala ggc Gly 150 caa Gin gaa Glu tea Ser gta Val gag Glu 230 caa Gin oaa Gin gtt Val cat His ttg Leu atg Met gao Asp 135 aag Lye gao Asp ttg Leu aaa Lys otc Leu 215 aaa Lye gca Ala 198 246 294 342 390 438 486 534 582 630 678 726 774 822 gga cac ago gtg otc cot aag ago acc aat gag got agg Gly His Ser 250 Vai Leu Pro Lys Ser Thr Aen Giu Ala Arg 255 260 ato aag aaa Ile Lye Lye
L
WO 99/25852 PCT/GB98/03464 aat ctt gac gtg tac gat tgg tct att. cct gaa gac ttg ttt ccc aag 870 Asn Lou Asp Val Tyr Asp Trp Ser Ile Pro Giu Asp Lou Phe Pro Lys 265 270 275 ttt tct gaa att aag cag gat aag cta, atc aag ggt acc ttt ttc gtt 918 Phe Ser Giu Ile Lys Gin Asp Lys Lou le Lys Gly Thr Phe Phe Val 280 285 290 295 aac gac acc tat ggt gct ttt agg acc att gaa gaa ctc tgg gat ggt 966 Asn Asp Thr Tyr Gly Aia Phe Arg Thr Ile Giu Giu Lau Trp Asp Gly 300 305 310 gaa gta tgagcaatat gcaacattga gatgacaaat aatacactgt ttccacaata, 1022 Giu Val aaaccagata ctgtttccat gataaagatt aaagctagat gctgatatga ttcgtgtaat 1082 tttaggttcc gtgaagtgtt actttctgta, taacaactgt aattcagatt aaagacatat 1142 ctgatgtttg acatttattg ttgtcgattc agacaagaca tcattgtacg tggttatatt 1202 taatctctaa tattgtctaa attattacc 1231 <210> 3 <211> 313 <212> PRT <213> Medicago sativa <400> 3 Met Ala Thr Ala Ile Lys Phe Phe Gin Lou Asn Thr Gly Ala Lys Ile 1 5 10 Pro Ser Vai Gly Leu Giy Thr Trp Gin Ala Giu Pro Gly Vai Vai Ala 25 Lys Ala Vai Thr Thr Ala Vai Gin Val Gly Tyr Arg His Ile Asp Cys 40 Ala Giu Ala Tyr Lys Asn Gin Ser Giu Ile Giy Ser Ala Leu Lys Lys 55 Lou Phe Giu Asp Giy Vai Vai Lys Arg Giu Giu. Leu Trp Ile Thr Ser 70 75 Lys Lou Trp Cys Ser Asp His His Pro Glu Asp Val Pro Lys Ala Leu 90 Asp Lys Thr Lou Asn Asp Leu Gin Lou Asp Tyr Leu Asp Lau Tyr Lou 100 105 110 le His Trp Pro Vai Ser Met Lys Arg Giy Thr Giy Giu Phe Met Gly 115 120 125 Glu Asn Leu Asp His Ala Asp Ile Pro Ser Thr Trp Lys Ala Leu Giy 130 135 140 Ala Leu Tyr Asp Ser Giy Lys Ala Lys Ala Ile Gly Vai Ser Asn Phe 145 150 155 160 WO 99/25852 Ser Thr Lys Lys Lou Gin Asp Lou Lou 165 Ala Val Asn Gin Val Giu. Lou His Pro 180 185 His Ala Phe Cys Giu Ser Lys Gly Ile 195 200 Lou Gly Ser Pro Giy Val Lou Lys Ser 210 215 Val Lys Glu Ile Ala Giu Lys Leu Gly 225 230 Lou Arg Trp Gly Lou Gin Ala Gly His 245 Asn Glu Ala Arg Ile Lys Lys Asn Lou 260 265.
Pro Glu Asp Lou Phe Pro Lys Phe Ser 275 280 Ile Lys Gly Thr Phe Phe Val Asn Asp 290 295 Ile Giu Glu Lou Trp Asp Gly Glu Val 305 310 <210> 4 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 4 cgaactcgag atggccacag caatcaagtt t <210> <211> 26 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> ccgagctcta cttcaccatc ccagag Asp 170 Gly His Asp Lys Ser 250 Asp Giu Thr Val Ala Arg Trp Gin Gin Lou Ser Giy 205 Ile Lou Lys 220 Thr Pro Giy 235 Val Lou Pro Val Tyr Asp le Lys Gin 285 Tyr Gly Ala 300 Val Ala 190 Tyr Asn Gin Lys Trp 270 Asp Phe PCT/GB98/03464 Pro Pro 175 Lys Lou Ser Pro Pro Vai Val Ala 240 Ser Thr 255 Ser Ile Lys Leu.
Arg Thr
Claims (20)
1. Use of an aldose reductase homologous protein superfamily member for the protection of a plant cell, plant or plant part against the deleterious effects of free radical generation.
2. Use of a nucleic acid encoding for an aldose reductase homologous protein superfamily member for the protection of a plant cell, plant or plant part against the deleterious effects of free radical generation.
3. Use as claimed in Claim 1 characterised in that nucleic acid is incorporated into the plant through molecular biological manipulation.
4. Use as claimed in Claims 2 or Claim 3 characterised in that the nucleic acid is expressed in vegetative or root tissue and/or in constituitive and/or non-temporal manner. A method for protecting a plant cell, or plant or plant part containing such cell, from the deleterious effects of both abiotic and biotic stress induced free radical generation, characterised in that it comprises increasing the plant cell levels of an aldose reductase homologous protein superfamily member such that is capable of reducing free radical generated toxic aldehydes through introduction of a nucleic acid encoding therefor into said cell.
6. A method as claimed in Claim 5 characterised in that it further comprises administering ammonium and/or sulphate ions to the cell or plant.
7. A method as claimed in Claim 6 characterised in that the ions are administered as ammonium sulphate solution. AMENDED SHEET -28- F:I\37\980\WOISPECNAM99I1130.DC
8. A plant cell comprising a heterologous nucleic acid encoding for an aldose reductase homologous protein, such that it overproduces or contains elevated levels of said protein as compared to a plant cell from which it is derived, characterised in that the aldose reductase homologous protein comprises a sequence having at least sequence identity with that of SEQ ID No 1 or 3.
9. A cell as claimed in Claim 8 characterised in that it has an enhanced resistance against stress conditions involving production of free radicals and against drought.
10. A cell as claimed in Claim 8 or Claim 9 characterised in that said aldose reductase-homologous protein is an aldose reductase-homologous protein originating from alfalfa (MsALRh protein) or a functional variant or derivative thereof.
11. A cell as claimed in any one of Claims 8 to 10 wherein said aldose reductase- homologous protein comprises the amino acid sequence shown in SEQ ID No 1 or 3 or a functional variant thereof comprising an amino acid sequence at least homology thereto.
12. A cell as claimed in any one of Claims 8 to 11 characterised in that the aldose reductase-homologous protein comprises an amino acid sequence having at least sequence homology to that of SEQ ID No 1 or 3.
13. A plant or plant part or plant breeding material comprising a cell as claimed in any one of Claims 8 to 12 having an enhanced resistance against both abiotic and biotic stress conditions involving production of free radicals.
14. A plant, part or material as claimed in Claim 13 characterised in that it has enhanced resistance against treatment with one or more of herbicides, heavy metals, hydrogen peroxide, ozone, flooding, NaC1, UV-B, photoinhibiting high light intensity, infection caused by viruses, bacteria or fungi; wounding and drought. -29- AMENDED SHEET A recombinant, isolated, enriched, or cell free nucleic acid molecule encoding for an aldose reductase-homologous protein comprising an amino acid sequence having at least 50% identity with amino acid sequence shown in SEQ ID No 1 or 3.
16. A nucleic acid molecule as claimed in Claim 15 characterised in that it encodes an aldose reductase homologous protein functional variant or derivative comprising an amino acid sequence having at least 70% homology to the amino acid sequence SEQ ID No 1 or 3.
17. A nucleic acid molecule as claimed in Claim 15 characterised in that it is capable of hybridizing with nucleic acid of SEQ ID No 2 under high stringency conditions.
18. A recombinant, isolated, enriched or cell free nucleic acid molecule characterised in that it comprises a polynucleotide or oligonucleotide fragment of or more contiguous bases of SEQ ID No 2 or a complementary sequence thereto.
19. A process for the preparation of a plant cell overproducing an aldose reductase-homologous protein comprising transforming a plant cell with a nucleic acid molecule according to any one of Claims 15 to 18.
20. A recombinant, isolated, enriched or cell free protein characterised in that it is an aldose reductase homologous protein comprising an amino acid sequence of at least 50% sequence identity to SEQ ID No 1 or SEQ ID No 3.
21. Use of a isolated, recombinant, enriched or cell free protein as claimed in Claim 20, or an epitopic part of said amino acid sequence having said identity, for the production of an antibody capable of specifically binding to such an aldose reductase homologous protein.
22. An antibody characterised in that it binds specifically to an aldose reductase homologous protein as claimed in Claim DATED this 1st day of August 2002 BTG INTERNATIONAL LTD WATERMARK PATENT TRADE MARK ATTORNEYS 290 BURWOOD ROAD HAWTHORN VICTORIA 3122 AUSTRALIA CJH/BJDNRH P17168AU00 9S 9 9 999
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9702118A HUP9702118A3 (en) | 1997-11-18 | 1997-11-18 | Plants over producing aldose reductase homologous protein can tolerate water deficiency and resist oxidative stresses, and process for producing them |
HU9702118 | 1998-04-21 | ||
PCT/GB1998/003464 WO1999025852A1 (en) | 1997-11-18 | 1998-11-18 | Stress resistance gene |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1167599A AU1167599A (en) | 1999-06-07 |
AU752803B2 true AU752803B2 (en) | 2002-10-03 |
Family
ID=89995761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11675/99A Ceased AU752803B2 (en) | 1997-11-18 | 1998-11-18 | Stress resistance gene |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1032690A1 (en) |
JP (1) | JP2001523466A (en) |
KR (1) | KR20010032243A (en) |
CN (1) | CN1292823A (en) |
AR (1) | AR017638A1 (en) |
AU (1) | AU752803B2 (en) |
BR (1) | BR9814644A (en) |
CA (1) | CA2309757A1 (en) |
HU (2) | HUP9702118A3 (en) |
NZ (1) | NZ503443A (en) |
WO (1) | WO1999025852A1 (en) |
ZA (1) | ZA9810540B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4312012B2 (en) | 2003-09-12 | 2009-08-12 | トヨタ自動車株式会社 | Paraquat® resistance gene and vascular and trichome specific promoters |
CN114015577B (en) * | 2021-11-03 | 2023-06-30 | 青岛科技大学 | Construction method of synechococcus strain with cadmium ion stress resistance |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2256856T3 (en) * | 1995-04-06 | 2006-07-16 | Seminis Vegetable Seeds, Inc. | TRANSGENIC CELL SECTION PROCESS. |
-
1997
- 1997-11-18 HU HU9702118A patent/HUP9702118A3/en unknown
-
1998
- 1998-11-18 ZA ZA9810540A patent/ZA9810540B/en unknown
- 1998-11-18 CA CA002309757A patent/CA2309757A1/en not_active Abandoned
- 1998-11-18 AR ARP980105855A patent/AR017638A1/en not_active Application Discontinuation
- 1998-11-18 WO PCT/GB1998/003464 patent/WO1999025852A1/en not_active Application Discontinuation
- 1998-11-18 CN CN98813179XA patent/CN1292823A/en active Pending
- 1998-11-18 JP JP2000521215A patent/JP2001523466A/en active Pending
- 1998-11-18 KR KR1020007005445A patent/KR20010032243A/en not_active Application Discontinuation
- 1998-11-18 HU HU0101283A patent/HU226743B1/en not_active IP Right Cessation
- 1998-11-18 BR BR9814644-0A patent/BR9814644A/en not_active IP Right Cessation
- 1998-11-18 NZ NZ503443A patent/NZ503443A/en unknown
- 1998-11-18 EP EP98954624A patent/EP1032690A1/en not_active Withdrawn
- 1998-11-18 AU AU11675/99A patent/AU752803B2/en not_active Ceased
Non-Patent Citations (3)
Title |
---|
EMBL SEQUENCE DATE LIBRARY ACC. NO. D90914 * |
EMBO. J 10(5), PP 1037, 1043 * |
PLANT CELL & ENVIRONMENT 17, PP 659-667 * |
Also Published As
Publication number | Publication date |
---|---|
AR017638A1 (en) | 2001-09-12 |
HUP9702118A3 (en) | 2000-08-28 |
BR9814644A (en) | 2000-10-03 |
EP1032690A1 (en) | 2000-09-06 |
CN1292823A (en) | 2001-04-25 |
HUP0101283A3 (en) | 2002-12-28 |
CA2309757A1 (en) | 1999-05-27 |
HU9702118D0 (en) | 1998-01-28 |
JP2001523466A (en) | 2001-11-27 |
NZ503443A (en) | 2002-03-01 |
KR20010032243A (en) | 2001-04-16 |
HUP9702118A2 (en) | 1999-07-28 |
ZA9810540B (en) | 2000-05-18 |
HU226743B1 (en) | 2009-08-28 |
WO1999025852A1 (en) | 1999-05-27 |
AU1167599A (en) | 1999-06-07 |
HUP0101283A2 (en) | 2001-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200113147A1 (en) | Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants | |
EP2295549A1 (en) | Nicotiana nucleic acid molecules and uses thereof | |
Le Deunff et al. | Oxidative burst and expression of germin/oxo genes during wounding of ryegrass leaf blades: comparison with senescence of leaf sheaths | |
BRPI0721100A2 (en) | METHOD FOR INTENSIFYING CHARACTERISTICS RELATED TO YIELD ON PLANTS, AND FOR THE PRODUCTION OF A TRANSGENIC PLANT, PLANT OR PART OF THE SAME, ISOLATED NUCLEIC ACID MOLECULE, ISOLATED POLYPEPTIDE, CONSTRUCTION, USE OF A BUILDING OF A BUILDING CONSTRUCTION, NUCLEIC ACID, PLANT, PART OF PLANT OR PLANT CELL, HARVEST PARTS OF A PLANT, AND, PRODUCTS | |
MXPA02000132A (en) | Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants. | |
Dhanaraj et al. | Isolation of a cDNA clone and characterization of expression of the highly abundant, cold acclimation-associated 14 kDa dehydrin of blueberry | |
Davoine et al. | Specific and constitutive expression of oxalate oxidase during the ageing of leaf sheaths of ryegrass stubble | |
AU752803B2 (en) | Stress resistance gene | |
JPH07507204A (en) | Systemin | |
JP4998809B2 (en) | Polypeptides for improving plant iron deficiency tolerance and use thereof | |
US6545202B2 (en) | Transgenic plant transformed with a translationally controlled tumor protein (TCTP) gene | |
CA2211018C (en) | Seed coat specific dna regulatory region and peroxidase | |
US6812338B2 (en) | Peroxisomal ascorbate peroxidase gene induced by high temperature stress and a transgenic plant exhibiting thermotolerance | |
EP3850087A1 (en) | Rice plant material resistant against biotic stress | |
AU769868B2 (en) | A method for evaluating the ability of a compound to inhibit the protoporphyrinogen oxidase activity | |
Murai et al. | Different transcriptional regulation of cytosolic and plastidic CuZn-superoxide dismutase genes in Solidago altissima (Asteraceae) | |
Feng et al. | Overexpression of Arabidopsis AtmiR408 gene in tobacco | |
US7354390B1 (en) | Seed coat specific nucleotide sequence encoding peroxidase | |
UA124831C2 (en) | A nucleic acid molecule for conferring insecticidal properties in plants | |
JP2002355040A (en) | Method for detecting enzyme modulator in biosynthetic pathway of carotenoid | |
EP2933328A1 (en) | Nicotiana nucleic acid molecules and uses thereof | |
WO2005033309A2 (en) | Plant promoters and methods of use thereof | |
Perl-Treves | Molecular cloning and expression of copper, zinc superoxide dismutases in tomato | |
クボアキヒロ et al. | Molecular Biological Research on Ascorbate Peroxidase and Glutathione Reductase in the Active Oxygen Scavenging System of Plants: Molecular Cloning and Analysis of Expression in Response to Air Pollutants | |
JP2000325081A (en) | Root cap-specific protein and its gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |